Efficacy of REAL-Time continuous glucose monitoring on glycaemic control and glucose variability in Type 1 diabetic patients treated with either insulin pumps or multiple insulin injection therapy

Appropriate use of REAL-Time CGM improved glyco-metabolic control in T1D patients. The effects of CGM were more evident in patients under MDI treatment, compared to CSII. Glucose variability, in addition to glycaemic control, was improved in compliant diabetic patients. This article is protected by copyright (Diabetes/Metabolism Research and Reviews)